Coei Biotech
Access
Information
The company was established in November 2020, focusing on the research and development ,production ,and sales of in vitro diagnostic reagent products. The company is equipped with a research and development center of 1100 square meters and a production workshop of 1600 square meters,which not only supports molecular diagnosis and immunochromatographic technology platforms,but also covers the development of new nano microspheres and other technologies in multiple fields,fully meeting the needs of product trial production verification and providing comprehensive support for the smooth transformation of products.
Relying on mature technology platforms ,the company has deeply explored and developed more than ten products in the fields of molecular,pathological diagnosisand immunochromatography,which have been successfully introduced to the market and widely used in various field. Nowadays,the company widely undertakes variousCDMO businesses.
Coei Biotech aims to create its own brand while providing services to other R&D enterprises,committed to providing one-stop solutions from product incubation to registration and listing.
